vs
DOMO, INC.（DOMO）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
DOMO, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$79.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -13.1%，领先397.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -0.5%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DOMO vs RIGL — 直观对比
营收规模更大
DOMO
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出21.6%
-0.5%
净利率更高
RIGL
高出397.1%
-13.1%
两年增速更快
RIGL
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $69.8M |
| 净利润 | $-10.4M | $268.1M |
| 毛利率 | 74.2% | 91.5% |
| 营业利润率 | -8.7% | 33.2% |
| 净利率 | -13.1% | 384.0% |
| 营收同比 | -0.5% | 21.2% |
| 净利润同比 | 44.6% | 1769.2% |
| 每股收益（稀释后） | $-0.25 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMORIGL
| Q4 25 | $79.4M | $69.8M | ||
| Q3 25 | $79.7M | $69.5M | ||
| Q2 25 | $80.1M | $101.7M | ||
| Q1 25 | $78.8M | $53.3M | ||
| Q4 24 | $79.8M | $57.6M | ||
| Q3 24 | $78.4M | $55.3M | ||
| Q2 24 | $80.1M | $36.8M | ||
| Q1 24 | $80.2M | $29.5M |
净利润DOMORIGL
| Q4 25 | $-10.4M | $268.1M | ||
| Q3 25 | $-22.9M | $27.9M | ||
| Q2 25 | $-18.1M | $59.6M | ||
| Q1 25 | $-17.7M | $11.4M | ||
| Q4 24 | $-18.8M | $14.3M | ||
| Q3 24 | $-19.5M | $12.4M | ||
| Q2 24 | $-26.0M | $-1.0M | ||
| Q1 24 | $-18.7M | $-8.2M |
毛利率DOMORIGL
| Q4 25 | 74.2% | 91.5% | ||
| Q3 25 | 74.8% | 93.2% | ||
| Q2 25 | 74.2% | 95.6% | ||
| Q1 25 | 74.4% | 91.7% | ||
| Q4 24 | 75.0% | 89.9% | ||
| Q3 24 | 74.3% | 85.5% | ||
| Q2 24 | 74.1% | 92.4% | ||
| Q1 24 | 76.3% | 93.1% |
营业利润率DOMORIGL
| Q4 25 | -8.7% | 33.2% | ||
| Q3 25 | -9.1% | 40.9% | ||
| Q2 25 | -17.9% | 60.1% | ||
| Q1 25 | -15.6% | 23.9% | ||
| Q4 24 | -13.9% | 28.9% | ||
| Q3 24 | -18.5% | 25.4% | ||
| Q2 24 | -26.8% | 1.2% | ||
| Q1 24 | -16.6% | -23.6% |
净利率DOMORIGL
| Q4 25 | -13.1% | 384.0% | ||
| Q3 25 | -28.8% | 40.2% | ||
| Q2 25 | -22.5% | 58.6% | ||
| Q1 25 | -22.4% | 21.5% | ||
| Q4 24 | -23.5% | 24.9% | ||
| Q3 24 | -24.9% | 22.5% | ||
| Q2 24 | -32.5% | -2.8% | ||
| Q1 24 | -23.3% | -27.9% |
每股收益（稀释后）DOMORIGL
| Q4 25 | $-0.25 | $14.11 | ||
| Q3 25 | $-0.56 | $1.46 | ||
| Q2 25 | $-0.45 | $3.28 | ||
| Q1 25 | $-0.45 | $0.63 | ||
| Q4 24 | $-0.48 | $0.82 | ||
| Q3 24 | $-0.51 | $0.70 | ||
| Q2 24 | $-0.69 | $-0.06 | ||
| Q1 24 | $-0.51 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $124.2M | $52.5M |
| 股东权益账面价值 | $-191.9M | $391.5M |
| 总资产 | $201.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DOMORIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | $47.2M | $108.4M | ||
| Q1 25 | $45.3M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $61.2M | $49.1M | ||
| Q1 24 | $60.9M | $49.5M |
总债务DOMORIGL
| Q4 25 | $124.2M | $52.5M | ||
| Q3 25 | $121.9M | $60.0M | ||
| Q2 25 | $119.7M | $60.0M | ||
| Q1 25 | $117.7M | $60.0M | ||
| Q4 24 | $115.6M | $60.0M | ||
| Q3 24 | $115.2M | $60.0M | ||
| Q2 24 | $114.1M | $60.0M | ||
| Q1 24 | $113.5M | $60.0M |
股东权益DOMORIGL
| Q4 25 | $-191.9M | $391.5M | ||
| Q3 25 | $-191.5M | $117.6M | ||
| Q2 25 | $-178.7M | $81.9M | ||
| Q1 25 | $-177.2M | $18.6M | ||
| Q4 24 | $-171.2M | $3.3M | ||
| Q3 24 | $-166.4M | $-14.6M | ||
| Q2 24 | $-163.5M | $-29.9M | ||
| Q1 24 | $-153.5M | $-31.7M |
总资产DOMORIGL
| Q4 25 | $201.6M | $513.6M | ||
| Q3 25 | $195.7M | $242.5M | ||
| Q2 25 | $189.7M | $206.7M | ||
| Q1 25 | $214.3M | $176.0M | ||
| Q4 24 | $190.2M | $164.0M | ||
| Q3 24 | $197.8M | $139.4M | ||
| Q2 24 | $204.4M | $128.4M | ||
| Q1 24 | $225.7M | $126.5M |
负债/权益比DOMORIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | — |
| 自由现金流率自由现金流/营收 | 1.4% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $9.9M | — |
8季度趋势，按日历期对齐
经营现金流DOMORIGL
| Q4 25 | $3.4M | $22.0M | ||
| Q3 25 | $3.4M | $24.0M | ||
| Q2 25 | $4.0M | $30.5M | ||
| Q1 25 | $8.9M | $-893.0K | ||
| Q4 24 | $-13.7M | $14.5M | ||
| Q3 24 | $-6.2M | $21.7M | ||
| Q2 24 | $1.9M | $302.0K | ||
| Q1 24 | $5.4M | $-5.0M |
自由现金流DOMORIGL
| Q4 25 | $1.1M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $1.0M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-8.4M | — | ||
| Q2 24 | $-625.0K | — | ||
| Q1 24 | $2.9M | — |
自由现金流率DOMORIGL
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | -20.3% | — | ||
| Q3 24 | -10.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | 3.6% | — |
资本支出强度DOMORIGL
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 3.1% | — |
现金转化率DOMORIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
RIGL
暂无分部数据
